> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guide on Revising ANDA Labeling
- URL: https://www.fdaweb.com/guide-on-revising-anda-labeling-2/
- Published: 2022-01-27T12:00:00.000Z
- Updated: 2026-09-14T17:30:22.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5151016

*Federal Register* notice: FDA is making available a draft guidance entitled “Revising ANDA Labeling Following Revision of the RLD Labeling.” This guidance provides recommendations for updating ANDA labeling following revisions to the reference-listed drug (RLD) labeling, including information on how to identify RLD labeling updates and how to submit labeling updates. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2022-01-27/pdf/2022-01577.pdf?ref=fdaweb.com).